EPS Diluted (Annual) Chart

View EPS Diluted (Annual) for CATX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Annual) Chart
Start Trial

Historical EPS Diluted (Annual) Data

View and export this data back to 2000. Start Trial.
Date Value
December 31, 2025 -1.397
December 31, 2024 -1.231
December 31, 2023 -1.738
June 30, 2022 -0.5122
June 30, 2021 -0.3265
June 30, 2020 -0.5114
June 30, 2019 -0.7689
June 30, 2018 -1.20
June 30, 2017 -1.10
June 30, 2016 -0.90
June 30, 2015 -0.70
June 30, 2014 -1.60
June 30, 2013 -1.10
Date Value
June 30, 2012 -1.20
June 30, 2011 -1.10
June 30, 2010 -1.80
June 30, 2009 -2.70
June 30, 2008 -3.70
June 30, 2007 -5.40
June 30, 2006 -6.80
June 30, 2005 -198.00
June 30, 2004 -45.00
September 30, 2002 -3.00
September 30, 2001 -3.00
September 30, 2000 0.00

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
Anika Therapeutics, Inc. -0.7588
MiMedx Group, Inc. 0.3244
ABVC BioPharma, Inc. -0.3933
Enovis Corp. -20.72
Edwards Lifesciences Corp. 1.810